Literature DB >> 19015863

Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.

Adele Woodhouse1, Claire E Shepherd, Anna Sokolova, Victoria L Carroll, Anna E King, Glenda M Halliday, Tracey C Dickson, James C Vickers.   

Abstract

Most cases of Alzheimer's disease (AD) are sporadic in nature, although rarer familial AD (FAD) cases have provided important insights into major pathological disease mechanisms. Mutations in the presenilin 1 gene (PS1) are responsible for the majority of FAD cases, causing an earlier age of onset and more rapid progression to end-stage disease than seen in sporadic AD. We have investigated the cytoskeletal alterations in neuritic AD pathology in a cohort of FAD cases in comparison to sporadic AD and pathologically aged cases. Tau-immunoreactive neurofibrillary tangle (NFT) loads were similar between PS1 FAD and sporadic AD cases. Similarly, plaque loads, both beta-amyloid (Abeta) and thioflavine S, in PS1 FAD and sporadic AD cases were not significantly different; however, in pathologically aged cases, they were significantly lower than those in PS1 cases, but were not different from sporadic AD cases. The 'cotton wool' plaque characteristic of PS1 cases did not demonstrate a high density of dystrophic neurites compared to other Abeta plaque types, but did demonstrate a localised mass effect on the neuropil. Despite minimal differences in plaque and NFT loads, immunolabelling demonstrated clear phenotypic differences in the NFTs and dystrophic neurites in PS1 FAD cases. Presenilin-1 cases exhibited significantly (P < 0.05) more tau-positive NFTs that were immunolabelled by the antibody SMI312 (anti-phosphorylated NF protein and phosphorylated tau) than sporadic AD cases. Presenilin-1 cases also exhibited numerous ring-like NF-positive and elongated tau-labelled dystrophic neurites, whereas these dystrophic neurite types were only abundant at the very early (pathologically aged cases) or very late stages of sporadic AD progression, respectively. These differences in cytoskeletal pathology in PS1 cases suggest an accelerated rate of neuritic pathology development, potentially due to mutant PS1 influencing multiple pathogenic pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015863     DOI: 10.1007/s00401-008-0458-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.

Authors:  Peng Liu; John H Reichl; Eshaan R Rao; Brittany M McNellis; Eric S Huang; Laura S Hemmy; Colleen L Forster; Michael A Kuskowski; David R Borchelt; Robert Vassar; Karen H Ashe; Kathleen R Zahs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation.

Authors:  Dibson D Gondim; Adrian Oblak; Jill R Murrell; Rose Richardson; Francine Epperson; Owen A Ross; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

3.  Presenilin-1 regulates the expression of p62 to govern p62-dependent tau degradation.

Authors:  Ying-Tsen Tung; Bo-Jeng Wang; Wen-Ming Hsu; Ming-Kuan Hu; Guor Mour Her; Wei-Pang Huang; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-06-23       Impact factor: 5.590

4.  Presenilin/gamma-Secretase and Inflammation.

Authors:  Carlos A Saura
Journal:  Front Aging Neurosci       Date:  2010-05-18       Impact factor: 5.750

5.  Con: Can neuropathology really confirm the exact diagnosis?

Authors:  Kurt A Jellinger
Journal:  Alzheimers Res Ther       Date:  2010-05-07       Impact factor: 6.982

Review 6.  Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease.

Authors:  S Hunter; C Brayne
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

7.  Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.

Authors:  Stanislaw Mitew; Matthew T K Kirkcaldie; Tracey C Dickson; James C Vickers
Journal:  Front Neuroanat       Date:  2013-09-26       Impact factor: 3.856

8.  Loss of presenilin function enhances tau phosphorylation and aggregation in mice.

Authors:  Carlos M Soto-Faguás; Paula Sanchez-Molina; Carlos A Saura
Journal:  Acta Neuropathol Commun       Date:  2021-09-30       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.